Researcher Database
JAPANESE
Researcher Database TOP
> KOSAKA YOSHIYUKI
（Last updated : 2026-03-24 08:54:20）
KOSAKA YOSHIYUKI
Department / Course
Kobe Gakuin University The Faculty of Rehabilitation Department of Occupational Therapy
Job
Professor
Profile
Academic background
Business career
Achievement
Book and thesis
Academic conference presentation
Academic background
1977/04/01～1983/03/31
Yamaguchi University Graduated
Kobe University
Business career
2025/04/01 ～
Professor Kobe Gakuin University The Faculty of Rehabilitation Department of Occupational Therapy
Book and thesis
2025/11
Papers
Retrospective study of stage IV extracranial germ cell tumors: A report from the Japan Children's Cancer Group Pediatrics Internationa 67 (1) (Co-authored)
2025/02
Papers
Cord Blood Transplantation Using Myeloablative Conditioning for Pediatric Advanced Myelodysplastic Syndrome in AMeD Syndrome With a Novel ADH5 Variant. Pediatr Blood Cance 72 (2) (Co-authored)
2025/02
Papers
Incidence of and factors associated with hypophosphatemia in children and adolescents receiving cancer treatment: A single-center, retrospective study European Journal of Pediatrics 184(2) (170) (Co-authored)
2025/02
Papers
Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia Int J Hematol 31 (122(2)),pp.284-294 (Co-authored)
2024/11
Papers
JCCG ALL-B12: Evaluation of Intensified Therapies with Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL\nJournal of Clinical Oncology logo Open access ORIGINAL REPORTS
Display All（156）
Academic conference presentation
2016/12
Continuous cytarabine plus dexamethasone in consolidation phase to patients with childhood ALL: result from Japan Association of Childhood Leukemia Study -- JACLS ALL02 protocol. (Annual Meeting of Maerican Society of Hematology)
2016/12
Landscape of Driver Mutations and Their Clinical Impacts in Pediatric Acute Lymphoblastic Leukemia (Annual Meeting of Maerican Society of Hematology)
2016/12
Risk-adjusted therapy of acute lymphoblastic leukemia can improve survival: Results of Japan Association Childhood Leukemia Study Group (JACLS) Protocol ALL-02 (Annual Meeting of Maerican Society of Hematology)
2016/12
Shift to Anti-Fibrinolysis on the Administration of L-Asparaginase (L-Asp) during Induction Therapy for Pediatric Acute Lymphoblastic Leukemia (ALL) (Annual Meeting of Maerican Society of Hematology)
2016/12
The outcome of low-risk childhood B-cell precursor ALL treated with the Japan Association of childhood Leukemia Study (JACLS) ALL-02 trial. (Annual Meeting of Maerican Society of Hematology)
Display All（31）